Herbal modulation of drug bioavailability: Enhancement of rifampicin levels in plasma by herbal products and a flavonoid glycoside derived from Cuminum cyminum

Phytotherapy Research

Volumn 21, Issue 2, 2007, Pages 157-163

  Sachin, B S ^a   Sharma, S C ^a   Sethi, S ^a   Tasduq, S A ^a   Tikoo, M K ^a   Tikoo, A K ^a   Satti, N K ^a   Gupta, B D ^a   Suri, K A ^a   Johri, R K ^a   Qazi, G N ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

Cuminum cyminum; Drug bioavailability; Flavonoid glycoside; Permeation; Rifampicin

Indexed keywords

3',5 DIHYDROXYFLAVONE 7 O BETA DEXTRO GALACTURONIDE 4' O BETA DEXTRO GLUCOPYRANOSIDE; FLAVONOID GLYCOSIDE; HERBACEOUS AGENT; RIFAMPICIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CUMIN; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG POTENTIATION; DRUG TRANSPORT; HERB DRUG INTERACTION; MUCOSA; NONHUMAN; RAT;

ANIMALS; ANTIBIOTICS, ANTITUBERCULAR; BIOLOGICAL AVAILABILITY; CELL MEMBRANE; CUMINUM; DRUG SYNERGISM; FEMALE; FLAVONOIDS; GLUCOSIDES; INTESTINAL MUCOSA; MALE; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; RATS, WISTAR; RIFAMPIN;

CUMINUM CYMINUM; RATTUS;

EID: 33846968840     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2046     Document Type: Article

References (36)

1. Aruna K, Rukkumani R, Varma PS, Menon VP. 2005. Therapeutic role of Cuminum cyminum on ethanol and thermally oxidized sunflower oil-induced toxicity. Phytother Res 19: 416-421.
2. Aungst BJ. 2005. Intestinal permeation enhancers. J Pharm Pharmacol 89: 429-442.
3. Boskabady M, Kiani S, Azizi H. 2005. Relaxant effect of Cuminum cyminum on guinea pig tracheal chains and its possible mechanism. Indian J Pharmacol 37: 111-115.
4. Brown JR, Collett JH, Attwood D, Ley RW, Sims EE. 2002. Influence of monocaprin on the permeability of a diacidic drug BTA-243 across Caco-2 cell monolayers and everted gut sacs. Int J Pharm 245: 133-142.
5. Cummins CL, Jacobson W, Benet LZ. 2002. Unmasking the dynamic interplay between intestinal P-glycoprotein, and CYP3A4. J Pharm Exp Ther 300: 1036-1045.
6. Deferme S, Augustijns P. 2003. The effect of food components on the absorption of P-gp substrate: a review. J Pharm Pharmacol 55: 153-162.
7. El-Negoumy SI, Mansour RMA. 1989. Flavone glycosides of Cuminum cyminum seeds. Fasc 40: 87-89.
8. Ernst JM. 2000. Herb-drug interactions: potentially important but woefully under-researched. Eur J Clin Pharmacol 56: 523-524.
9. Iacobellis NS, Lo Cantore P, Capasso F, Senatore F. 2005. Anti-bacterial activity of Cuminum cyminum L. and Carum carvi L. essential oils. Agric Food Chem 53: 57-61.
10. Ishikawa T, Takayanagi T, Kitazima J. 2002. Water soluble constituents of cumin: monoterpene glucosides. Chem Pharm Bull 50: 1471-1478.
11. Janahmadi M, Niazi F, Danvali S, Kamalinejad M. 2005. Effects of the fruit essential oil of Cuminum cyminum Linn. (Apiaceae) on pentylenetetrazole-induced epileptiform activity in F1 neurons of Helix aspersa. J Ethnopharmacol 104: 278-282.
12. Khafagy SM, Sarg TM, Abdel Salem NA, Gabr O. 1978. Isolation of two flavone glycosides from the fruits of Cuminum cyminum grown in Egypt. Pharmazie 33: 296-297.
13. Kitazima J, Ishikawa T, Fuzimatu E, Kondho K, Takayanagi T. 2003. Glycosides of 2-C-methyl-D-erythritol from the fruits of anise, coriander and cumin. Phytochemistry 62: 115-120.
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with Folin phenol reagent. J Biol Chem 193: 265-275.
15. 1 cells. Eur J Pharmacol 483: 19-28.
16. Malini T, Vanithakumari G. 1987. Estrogenic activity of Cuminum cyminum in rats. Indian J Exp Biol 25: 442-444.
17. Mariappan TT, Singh S. 2004. Evidence of efflux-mediated and saturable absorption of rifampicin in rat intestine using the ligated loop and everted gut sac techniques. Mol Pharm 1: 363-367.
18. Mhaskar KS, Blatter E, Caius JF (eds). 2000. In Kiritikar & Basu's Illustrated Indian Medicinal Plants. Satguru Publications: New Delhi, vol 5, 1704-1705.
19. Nalini N, Sabitha K, Vishwanathan P, Menon VP. 1998. Influence of spices on the bacterial (enzyme) activity in experimental colon cancer. J Ethnopharmacol 62: 15-24.
20. Nostro A, Cellini L, Di Bartolomeo S et al. 2005. Anti-bacterial effect of plant extracts against Helicobactor pylori. Phytother Res 19: 198-202.
21. Notary RE. 1980. Biopharmaceutics and Clinical Pharmacokinetics. An Introduction, 3rd edn. Marcel Dekker: New York, Basel.
22. Petri WA Jr. 2001. Drugs used in the chemotherapy of tuberculosis, Mycobacterium avium complex disease, and leprosy. In Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10th edn. McGraw-Hill Medical Publishing Division: New York, 1273-1294.
23. Roman-Ramos R, Flores-Saenz JL, Alarcon-Aguilar FJ. 1995. Anti-hyperglycemic effect of some edible plants. J Ethnopharmacol 48: 25-32.
24. Sambaiah K, Srinivasan K. 1991. Effect of cumin, cinnamon, ginger, mustard and tamarind-induced hypercholesterolemic rats. Nahrung 35: 47-51.
25. Sandstrom R, Lennernas H. 1999. Repeated oral rifampicin decreases the jejunal permeability of R/S-verapamil in rats. Drug Metab Dispos 27: 951-955.
26. Satyanarayana S, Sushruta K, Sarma GS, Srinivas N, Subba Raju GV. 2004 Anti-oxidant activity of the aqueous extract of spicy food additives - evaluation and comparison with ascorbic acid in in vitro systems. J Herbal Pharmacother 4: 1-10.
27. Shishoo CJ, Shah SA, Rathod IS, Savale SS, Vora MJ. 2001. Impaired bioavailability of rifampicin in presence of isoniazid from fixed dose combination (FDC) formulation. Int J Pharm 228: 53-67.
28. Singh S, Mariappan TT, Sankar R, Sarda N, Singh B. 2001. A critical review of the probable reasons for the poor/variable bioavailability of rifampicin from anti-tubercular fixed dose combination (FDC) products, and the likely solutions to the problem. Int J Pharm 228: 5-17.
29. Srinivasan K. 2005. Plant foods in the management of diabetes mellitus: Spice as beneficial antidiabetic food adjuncts. Int J Food Sci Nutr 56: 399-414.
30. Takayanagi T, Ishikawa T, Kitazima J. 2003. Sesquiterpene lactone glucosides and alkyl glucosides from the fruit of cumin. Phytochemistry 63: 479-484.
31. Tasduq SA, Singh K, Satti NK, Gupta DK, Suri KA, Johri RK. 2006. Terminalia chebula (fruit) prevents liver toxicity caused by sub-chronic administration of rifampicin, isoniazid and pyrazinamide in combination. Hum Exp Toxicol 25: 1-8.
32. Tirumalasetty PP, Eley JG. 2006. Permeability enhancing effects of the alkylglycosides, octylglucoside on insulin permeation across epithelial membrane in vitro. J Pharm Pharm Sci 9: 32-39.
33. Venkataramanan RR, Komoroski B, Strom S. 2006. In vitro and in vivo assessment of herb-drug interactions. Life Sci 27: 2105-2115.
34. Wacher VJ, Wu C-Y, Benet LZ. 1995. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 13: 129-134.
35. Wang X, Wolkoff AW, Morris ME. 2005. Flavonoids as a novel class of human organic anion-transporting polypeptide OAT1B1 (OATP-C) modulators. Drug Metab Dispos 33: 1666-1672.
36. Zhou S, Lim LY, Chowbay B. 2004. Herbal modulation of P-glycoprotein. Drug Metab Rev 36: 1-48.